Pfizer close to buying Medivation, ChemChina gets US nod for Syngenta deal
Pfizer's takeover talks with Medivation are at an advanced stage, so say the Financial Times, Wall Street Journal and Bloomberg.
Company
Pfizer Inc
NYSE:PFE
Pfizer Inc is a research-based biopharmaceutical company. The company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1.
293 stories · page 13 of 15
Medivation faces buyers’ scrum - report
A scrum to acquire US cancer drug company Medivation was emerging on Wednesday after reports that Merck, Pfizer and Gilead Sciences were among at least five pharmaceutical companies expressing an interest
Radius Health shares rise 10% on continued bid rumours
Radius Health Inc shares were 10% higher on Friday on continued bid rumours
Trending: Brexit seen as a lever to more transatlantic M&A
When Brexit was first mooted by the Leave camp over a year ago, the slogan was all about taking back control of sovereignty and executive powers from the European Union. No one ever saw it as a conduit for taking control of US companies, di
Medivation rejects latest Sanofi bid
Medivation officially rejects the latest acquisition bid of US$58 per share from Sanofi.
Pharma Pfizer unfazed after Jefferies trims price target
Pharmaceuticals behemoth Pfizer Inc shares remained resilient after broker Jefferies trimmed its price target on the pharmaceutical giant's stock to $42 from $40, as Pfizer leadership prepares to decide whether to separate its global establ
Pfizer treatment passes second efficacy trial for psoriatic arthritis
The disease is normally associated with people suffering from psoriasis
US stocks receive lift from M&A activity in pharma sector
Merger activity and a resurgent oil price have lit a fire under US equities
Pharma M&A activity provides some juice for US stocks
Merger activity and a resurgent oil price have lit a fire under US equities
Trending: Macys, Staples and the worst Wall Street M&A year on record
If the oil and commodities sectors have had a rough ride this year, traders' shun words on Wednesday on Wall Street were Macys, Staples, and retail as US faces up to worst M&A deal failures on record
Allergan shares rise after $10bn buyback plan
Allergan shares rise after the company says it will buy back up to $10bn in stock following a swing to a first-quarter profit on a surge in sales of key drugs, including the wrinkle and muscle spasm treatment Botox
Archive
Pfizer a buy at lower levels, says Jefferies
Pfizer, one of the world's biggest pharmaceutical companies, may well be licking its wounds after the collapse of its planned merger with Allergan this week, but brokers at Jefferies reiterate a Buy on the stock
Archive
Brokers: Chip giants in focus
Graphics chip maker Nvidia's analyst day was well-attended. Meanwhile, RBC is perturbed at the number of top executives leaving Intel.
US investors sit on their hands ahead of Fed minutes
Neither Pfizer or Allergan showed any ill effects from the collapse of the proposed merger
Wall Street shares push higher after shock US oil inventories drop, Fed sidelined
US small-cap stocks swing higher after a surprise drop in US weekly oil inventories boosts energy futures and calm jitters over minutes of the Federal Reserve's recent rate-setting meeting
US investors sit on their hands ahead of Fed minutes
Neither Pfizer or Allergan showed any ill effects from the collapse of the proposed merger
Stocks tread water ahead of Fed minutes
Neither Pfizer or Allergan showed any ill effects from the collapse of the proposed merger
Stocks set for strong start ahead of release of FOMC minutes
Pfizer is likely to be in focus after it called off its proposed acquisition of Allergan
Trending: Pfizer tie up with Allergan catches a cold
Not for the first time has the ambitious and acquisitive pharmaceutical behemoth Pfizer has been upset at the merger altar, but with its Allergan deal under threat, the company may well step back and assess shareholder value
Archive
Papers: Pfizer Inc-Allergan deal in doubt after tax changes
Also mentioned: Tesla, Walt Disney, Yahoo and Twitter